(Q43299881)

English

Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms

scientific article published on 31 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

0 references

immunohistochemistry

1 reference

based on heuristic

inferred from title

thymic carcinoma

1 reference

based on heuristic

inferred from title

9

object named as

Atsushi Ochiai

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Genichiro Ishii

2

object named as

Genichiro Ishii

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Tomoyuki Hishida

5

object named as

Tomoyuki Hishida

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

8

object named as

Kanji Nagai

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

3

object named as

Junji Yoshida

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Yukinori Murata

7

object named as

Yukinori Murata

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Masakazu Kojika

1

object named as

Masakazu Kojika

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Mituyo Nishimura

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Shu-ji Ota

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

31 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

1341-1350

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.105

0 references

CD5 immunoreactivity of epithelial cells in thymic carcinoma and CASTLE using paraffin-embedded tissue

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

CD5 labeling of thymic carcinomas and other nonlymphoid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Differences in clinicopathological and biological features between central-type and peripheral-type squamous cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Structure, function, and regulation of the mammalian facilitative glucose transporter gene family

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Expression of glucose transporters in head-and-neck tumors.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Role of flourine-18 fluorodeoxyglucose positron emission tomography in thymic pathology.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Application of positron emission tomography imaging to cancer screening

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

21 January 2018

Squamous cell carcinoma of the thymus. An analysis of eight cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoreactivity of a new CD5 antibody with normal epithelium and malignant tumors including thymic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical KIT (CD117) expression in thymic epithelial tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytokeratins in normal thymus and thymic epithelial tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.2009.105

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43299881&oldid=1985762316"